Polyrizon Ltd.

Biotechnology · RAANANA, L3

BiotechnologySEC Form D

Polyrizon Ltd. filed a Form D with the U.S. Securities and Exchange Commission on April 23, 2026, reporting $3,499,992 raised.

Incorporated in Israel and based in RAANANA, L3, it operates in the Biotechnology sector.

Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Polyrizon Ltd. has raised capital from private investors.

Browse more recently funded companies in Biotechnology.

Executives & Directors

  • Tomer IzraeliExecutive Officer · Director
  • Nir Ben YosefExecutive Officer
  • Eyal RonExecutive Officer
  • Tidhar TurgemanExecutive Officer
  • Asaf ItzhaikDirector
  • Oz AdlerDirector
  • Liat SidiDirector
  • Yehonatan Zalman VinokurDirector
  • Liron CarmelDirector

Recently funded in Biotechnology

Other companies that recently filed a Form D

$3.2MRaised

Goldenrod Therapeutics, Inc.

BiotechnologyHOUSTON, TX
May 26, 2026View SEC Form D
$10.0MRaised

Human Biotech, Inc.

BiotechnologyCAMBRIDGE, MA
May 22, 2026View SEC Form D
$1.0MRaised

Optimeos Life Sciences, Inc.

BiotechnologyPRINCETON, NJ
May 22, 2026View SEC Form D
$2.5MRaised

BioStem Technologies, Inc.

BiotechnologyPOMPANO BEACH, FL
May 21, 2026View SEC Form D
$10.0MRaised

Senti Biosciences Holdings, Inc.

BiotechnologySouth San Francisco, CA
May 20, 2026View SEC Form D
Polyrizon Ltd. raised $3.5M — SEC Form D